Literature DB >> 19145102

Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys.

Matthew L Banks1, Daniel F Manvich, Rayna M Bauzo, Leonard L Howell.   

Abstract

BACKGROUND: Cocaine and methamphetamine (METH) are two commonly abused drugs that have behavioral-stimulant properties. These stimulant effects are partially mediated by the dopaminergic system. Recent evidence has suggested that the histamine H(3) receptor (H(3)R) may modulate the release of dopamine induced by METH. The aim of the present study was to examine the role of H(3)R in the behavioral-stimulant effects of cocaine and METH in mice and monkeys.
METHODS: Nonhabituated, experimentally naïve mice (n = 5-6) were pretreated with the H(3)R agonist imetit 30 min before METH or cocaine, and activity was measured for 90 min. The behavioral-stimulant effects of METH and cocaine were also studied in squirrel monkeys (n = 3) under a fixed-interval schedule of stimulus termination. Monkeys were pretreated with imetit 30 min before the peak behavioral-stimulant doses of METH or cocaine derived from individual subjects.
RESULTS: Pretreatment with imetit did not affect basal activity in mice. Imetit significantly attenuated the behavioral-stimulant effects of METH, but not cocaine. In monkeys, no dose of imetit tested significantly altered the behavioral-stimulant effects of METH or cocaine.
CONCLUSION: These results suggest a role of H(3)R in the behavioral-stimulant effects of METH, but not cocaine, in mice and no role in monkeys. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19145102      PMCID: PMC2834261          DOI: 10.1159/000191473

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  24 in total

1.  Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit.

Authors:  F P Jansen; T Mochizuki; K Maeyama; R Leurs; H Timmerman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-07       Impact factor: 3.000

Review 2.  The role of histamine and the tuberomamillary nucleus in the nervous system.

Authors:  Helmut Haas; Pertti Panula
Journal:  Nat Rev Neurosci       Date:  2003-02       Impact factor: 34.870

3.  Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function.

Authors:  Carla Ferrada; Sergi Ferré; Vicent Casadó; Antonio Cortés; Zuzana Justinova; Chanel Barnes; Enric I Canela; Steven R Goldberg; Rob Leurs; Carme Lluis; Rafael Franco
Journal:  Neuropharmacology       Date:  2008-05-16       Impact factor: 5.250

4.  Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor.

Authors:  S Morisset; C Pilon; J Tardivel-Lacombe; D Weinstein; W Rostene; C Betancur; P Sokoloff; J C Schwartz; J M Arrang
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

5.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations.

Authors:  J M Arrang; J Roy; J L Morgat; W Schunack; J C Schwartz
Journal:  Eur J Pharmacol       Date:  1990-04-25       Impact factor: 4.432

7.  Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys.

Authors:  Paul W Czoty; Brett C Ginsburg; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

8.  Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat.

Authors:  K Itoh; R Fukumori; Y Suzuki
Journal:  Life Sci       Date:  1984-02-27       Impact factor: 5.037

9.  Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release.

Authors:  Patrik Munzar; Gianluigi Tanda; Zuzana Justinova; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2004-04       Impact factor: 7.853

10.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor.

Authors:  J M Arrang; M Garbarg; J C Schwartz
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

View more
  6 in total

1.  The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys.

Authors:  Daniel F Manvich; Heather L Kimmel; Debra A Cooper; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2012-06-08       Impact factor: 4.030

2.  Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys.

Authors:  Daniel F Manvich; Heather L Kimmel; Leonard L Howell
Journal:  J Pharmacol Exp Ther       Date:  2012-02-10       Impact factor: 4.030

Review 3.  Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders.

Authors:  Patricia Di Ciano; Christian S Hendershot; Bernard Le Foll
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Influence of the novel histamine H₃ receptor antagonist ST1283 on voluntary alcohol consumption and ethanol-induced place preference in mice.

Authors:  Amine Bahi; Bassem Sadek; Stephan J Schwed; Miriam Walter; Holger Stark
Journal:  Psychopharmacology (Berl)       Date:  2013-03-09       Impact factor: 4.530

5.  The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons.

Authors:  Maximiliano Rapanelli; Luciana R Frick; Kyla D Horn; Rivka C Schwarcz; Vladimir Pogorelov; Angus C Nairn; Christopher Pittenger
Journal:  J Biol Chem       Date:  2016-08-10       Impact factor: 5.157

6.  Decrease of cocaine, but not heroin, self-administration and relapse by the tyrosine kinase inhibitor masitinib in male Sprague Dawley rats.

Authors:  A Belin-Rauscent; J Lacoste; O Hermine; A Moussy; B J Everitt; David Belin
Journal:  Psychopharmacology (Berl)       Date:  2018-03-08       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.